INTRODUCTION
The antiviral properties of the glycoproteins called the interferons have been the subject of numerous investigations since their discovery over two decades ago (I). Only in recent years has come the recognition that interferon (IF)* can also exert a variety of significant effects upon immunological functions. One of these effects is the enhancement by IF of natural killer (NK) cell activity, a lymphocyte-mediated cytotoxic reaction against virus-infected or malignantly transformed target cells which does not require previous exposure of the effector cells to the targets .
The subset of lymphocytes mediating NK activity in man has not been completely defined, although a number of methods have been used to further purify hNK effector cells. These include enrichment of cells with Fc receptors (6) , adsorption and elution from target cells, and density and velocity fractionation (7) . Recently, the latter technique has been utilized by Timonen and Saksela (8) , who devised a density gradient of a colloidal silica medium (Percoll) which permits considerable enrichment of NK effector cells. Using a modification of this procedure, we have obtained a highly enriched population of NK effect-or cells from 375 human peripheral blood. We were thus able to examine the effects of IF upon the cells more directly responsible for mediating the NK reaction.
Interest in the mechanisms of NK ceil activity has been increasing due to its potential role in immunologic defense against tumors (9) (10) (11) (12) (13) (14) , and self-regulation of lymphoid cell functions (15) (16) (17) . The antitumor properties of IF are also currently under investigation, both in the laboratory and in clinical trials (18) . Since the ability of IF to act against malignant cells in man may be partially due to its enhancement of the NK reaction, it is important to gain greater knowledge of the events involved in this enhancement. The cellular and biochemical mechanisms associated with IF-mediated augmentation of the NK reaction are still largely unknown.
Although natural cytotoxicity has been observed in both murine and human systems, significant interspecies differences exist in its expression. An age-related decline in murine NK activity is not paralleled in man (19) . While the greatest tissue-associated murine NK activity is observed in spleen, in man peripheral blood lymphocytes manifest the highest NK activity, and human NK cells are significantly more radiosensitive than their murine counterparts (7). We thus examined IF-enhanced NK activity in the human to compare the biochemical requirements of this enhancement to those in the mouse (20, 21) . The present study extends previous investigations in which total human peripheral blood mononuclear cells (PBMC) were used (22) by utilizing a highly enriched population of NK effector lymphocytes. Since total PBMC contain cell populations which can themselves modify NK activity, it is important to determine the effects of IF on purified NK effector cell populations.
MATERIALS AND METHODS
Lymphocyte separation. PBMC were separated from heparinized venous blood of healthy adult donors by Ficoll-Hypaque density gradient centrifugation (23) . Cells were washed three times with 0.85% NaCl and resuspended in RPM1 1640 culture medium containing 5% fetal calf serum, fresh glutamine (300 pg/ml), and antibiotics (hereafter referred to as complete medium, CM). Cells were depleted of monocytes by incubation on a column of Sephadex G-10 (Pharmacia Chemicals, Piscataway, N.J.) according to the method of Ly and Mishell (24) . Cells eluted from this column contained < 1% esterase-positive monocytes.
Percoll enrichment of NK effector cells. Discontinuous density gradients of Percoll (Pharmacia) were prepared as described by Timonen and Saksela (8) with slight modifications.
Percoll was diluted to various concentrations in RPM1 1640 medium, and 2-ml volumes of each fraction were layered into a 15 x 10.5mm glass test tube. These gradients consisted of six fractions, starting with 50% Percoll (fraction 5) and decreasing by 2.5% increments to 37.5% (fraction 0). Monocytedepleted lymphocytes were layered on top of this gradient and centrifuged at 300 g for 45 min at 22°C. Fractions were collected with a Pasteur pipet and washed twice in CM.
Results of 18 experiments consistently demonstrated the highest NK activity in fractions 0 and 1 (Fig. 1) . We then employed a simpler, three-layer gradient to enrich for NK effecters in subsequent experiments. This gradient consisted of 4-ml layers of 40,45, and 50% Percoll in a 15 x 105mm glass tube. Centrifugation was performed as above, and the cells from the 40% interface were used as NK effector cells in all subsequent experiments. Cells found at this 40% interface were shown in eight experiments to possess NK activity not significantly different from cells found at the fraction 0 interface in the six-layer gradient.
NK target cells. The human leukemic cell line, K562, recently shown to be of probable erythroid origin (25) , was used as targets for NK cells. K562 cells passaged 48 hr prior to the day of use were labeled by the addition of 200 ,uCi of Na, Wr04 (200-500 Ci/g, New England Nuclear, Boston, Mass.) to 5 x 106: K562 cells in 0.8 ml CM. The cells were incubated for 1 hr at 37°C in a humid 5% CO,, 95% air atmosphere, with frequent shaking. Cells were then washed three times with CM and resuspended to a concentration of 1Ojiml.
NK cytotoxicity assay. NK activity was measured by a 4 hr direct SLCr-release assay, except where noted. The effector-to-target ratio was 20: 1 in all experiments unless stated otherwise, as this ratio was selected from a number of previously tested ratios as providing optimal results. Thus, 2 x lo5 viable effector cells were added to IO4 labeled viable target cells in triplicate cultures of 0.2 ml each in V-bottom microtitration plates (Costar, Cambridge, Mass.). Plates were centrifuged at 40g for 5 min, then incubated 4 hr at 37°C in a humid 5% CO.), 95% air atmosphere. At the completion of incubation, plates were centrifuged at 700g for 5 min, and 0.1 ml of culture supernatant was harvested from each well and where spontaneous release represents counts released from wells containing IO4 target cells alone, and total counts represents counts contained in an aliquot of 104 target cells. IF augmentation of NK effector cells. NK effector cells, isolated as described above, were suspended at a cell density of 5 x lo6 cells/ml in CM containing 500 U/ml of partially purified human leukocyte IF (sp act 6.3 x 104 units/mg protein, a kind gift from Parke-Davis and Co., Detroit, Mich.). Cells were incubated with IF for 1 hr at 37°C in a humid 5% COz, 95% air atmosphere, except where noted, and were washed prior to use.
Drug treatments. Cells were incubated at a density of 5 x lo6 cells/ml in CM containing the stated concentrations of drugs, at 37°C. All incubations with drugs lasted 45 min except incubations with puromycin (PM), which were maintained for 1 hr. Cells were washed following treatment unless stated otherwise. The drugs used, mitomycin C (MC), actinomycin D (AD), emetine HCI (EM), and puromytin (PM), were all purchased from Sigma Chemical Company, St. Louis, Missouri. None of the drug treatments decreased cell viability as determined by trypan blue exclusion. All drug solutions were prepared fresh on the day of use.
Assays of DNA, RNA, and protein synthesis. Following drug and/or IF treatments, aliquots of each experimental effector cell suspension were used to simultaneously assay NK activity and DNA, RNA, or protein synthesis. The latter were quantitated via the incorporation of [3H]thymidine, [3H]uridine, and [3H]leucine, respectively. All radiochemicals were purchased from New England Nuclear, Boston, Massachusetts. In these assays, 5 fig of phytohemagglutinin-P (PHA, Difco, Labs, Detroit, Mich.) were added to each culture well. Control cultures without PHA were included in each experiment, and although the absolute incorporation of radiolabel was consistently greater in the mitogen-stimulated cultures, the qualitative pattern of the drug effects on stimulated and unstimulated cultures was comparable.
To assay DNA synthesis, 2 x lo5 cells were incubated in a volume of 0.2 ml of CM in triplicate in round-bottom microtitration plates (Costar). Cultures were incubated at 37°C for 72 hr; 18 hr prior to harvesting, 2 @i of [3H]thymidine (6.7 Cilmmol) were added to each well. Cultures were harvested onto glass fiber filters using an automated cell harvester. Filters were dried and placed in scintillation vials containing 1 ml of Hydrofluor (National Diagnostics, Somerville, N.J.). Vials were counted in a Beckman Model LS 7000 scintillation counter.
To assay RNA synthesis, cells were plated as described above and cultured for 18 hr in the presence of [3H]uridine (37.6 Wmmol) at 1 &i/well.
The cells were harvested on glass fiber filters as above and acid-precipitable material was precipitated with 6% sulfosalicylic acid. Filters were dried and counted as above.
To assay protein synthesis, cells in CM were centrifuged following removal of aliquots for NK assay, and resuspended in leucine-free minimal essential medium containing 5% fetal calf serum. we additionally demonstrate that protein synthesis is required for at least 1 hr following removal from IF-containing medium. Binding of IF to cells, however, seems independent of protein synthesis. A requirement for protein synthesis is also a feature of IF-mediated induction of viral resistance (18) , and specific enzymatic activities are known to be induced in IF-treated cells concomitant with the induction of viral resistance (30) .
Although a number of similarities exist in the metabolic requirements for IFmediated enhancement of NK activity and induction of viral resistance, indicating that the two processes may occur via related biochemical events, it is unlikely that they possess identical mechanisms. Whereas the present study has shown that IF-mediated augmentation of NK cells is essentially complete by 60 min, the antiviral state is not usually conferred upon cells until 6-12 hr after exposure to IF (31) . Thus, it is probable that the specific RNA and protein species necessary for development of increased NK activity and viral resistance differ, as well as the cell populations affected.
A number of specific proteins could be involved in the enhancement of NK cell reactivity induced by IF. Treatment of human ftbroblasts with IF induces the synthesis of at least 12 polypeptides (32), and recent evidence implies that serinedependent proteases are necessary to the NK reaction (33) , along with an intact secretory apparatus (34) . It is conceivable that IF could enhance NK activity by increasing the rate of synthesis or activity of proteins involved in the cytotoxic event.
Alternatively, IF could enhance NK activity in a less direct manner, perhaps by the induction of one or more lymphokines which are themselves able to stimulate NK activity.
It has recently been shown that the T-cell growth factor, interleukin-2 (IL-2), increases the growth and cytotoxic activity of murine NK cells in culture (35) . IF may allow NK cells to bind greater amounts of IL-2, or IF-augmented NK cells may secrete IL-2.
IF may also alter membrane receptors or target recognition sites on N K effector cells. IF appears to induce increased expression of the murine H-2 and human HLA antigens on cell surfaces (18) , and IF may affect the expression or configuration of NK-specific structures on the effector cell membrane.
The present study has defined the metabolic requirements of the augmentation by IF of a highly enriched population of NK effector cells. It is evident, however, that much remains to be determined about the molecular mechanisms by which IF modulates the NK reaction. Our data strongly support the concept that IF acts upon a preexisting population of NK cells to increase their activity, rather than by causing their proliferation.
This activation occurs rapidly, is temperature independent, and requires de ~OVO RNA and protein synthesis. Proteins involved in the augmentation process may include cytotoxic proteins, lymphokines, or effector cell recognition structures. We are currently investigating these possibilities to gain increased insight into the cellular and molecular events associated with IFmediated NK cell activation.
